Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
IntroductionMetabolic dysfunction-associated steatotic liver disease (MASLD) is a major public health concern that is exacerbated by the obesity pandemic. Dietary interventions have the potential to alleviate obesity-associated MASLD through variable mechanisms, including optimizing the gut microbio...
Saved in:
| Main Authors: | Reza Hakkak, Soheila Korourian, Wei Li, Beverly Spray, Nathan C. Twaddle, Christopher E. Randolph, Elisabet Børsheim, Michael S. Robeson II |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-10-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2024.1487859/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity and Dietary Soy Protein With Different Isoflavone Levels Alter Fecal Microbial Composition in Zucker Rats Over 9- and 18-Week Periods
by: Reza Hakkak, et al.
Published: (2025-05-01) -
Debunking the myth: are soy isoflavones truly a public health concern?
by: Miguel López-Moreno, et al.
Published: (2025-07-01) -
Effect of soy isoflavones on intraepithelial lymphocytes, goblet cells and long leptin receptor in intestinal of rats
by: TANG Xiuying, et al.
Published: (2013-05-01) -
Saponins in soy reduce NNK-induced lung cancer by increasing plasma isoflavone levels
by: Ingrid Elisia, et al.
Published: (2025-04-01) -
Soy Isoflavones and PCOS: Role in Hormonal and Metabolic Mechanisms
by: Katarzyna Dereń, et al.
Published: (2025-05-01)